Phase II/III Study of S-877503 in Pediatric Patients with Attention-deficit/Hyperactivity Disorder -Long term Extension Study
Phase 2
- Conditions
- Attention-deficit/Hyperactivity Disorder
- Registration Number
- JPRN-jRCT2080222071
- Lead Sponsor
- SHIONOGI & CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patient has completed 9-week administration and the last examination at Visit 9 in the preceding study of S-877503 in pediatric patients with ADHD. And et al.
Exclusion Criteria
1) Patient has complications such as serious hepatic disorder, renal disorder, heart disease,
lung disease, hematological disease, and metabolic disease.
2) Patient considered a suicide risk. And et al.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety
- Secondary Outcome Measures
Name Time Method